Three new, mixed-valent layered vanadyl phosphates, Ag(0.43)VOPO(4).2H(2)O (AgVPO), Cu(0.16)VOPO(4).2.5H(2)O (CuVPO), and Zn(0.11)VOPO(4).2.5H(2)O (ZnVPO), have been synthesized hydrothermally and their structures determined by single-crystal X-ray diffraction: AgVPO is triclinic, space group P, a = 6.287(1), b = 6.283(1), and c = 13.240(1) Å, alpha = 80.98(1), beta = 86.58(1) and gamma = 90.00(1) degrees, Z = 4; CuVPO is triclinic, space group P, a = 6.260(2), b = 6.249(3), and c = 7.257(1) Å, alpha = 83.62(3), beta = 73.99(2), and gamma = 90.13(4) degrees, Z = 2; ZnVPO is triclinic, space group P, a = 6.252(1), b = 6.248(2), and c = 7.339(3) Å, alpha = 83.24(4), beta = 73.93(2), and gamma = 90.00(2) degrees, Z = 2. The structures are related to that of VOPO(4).2H(2)O. Metal powders have been found to be effective both as reductants and as countercations.
No takes yet. Share an insight, caveat, or question.
Ayyappan et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: